Nightingale Health Eo Stock Current Valuation
| 7XE Stock | EUR 2.81 0.12 4.10% |
Valuation analysis of NIGHTINGALE HEALTH helps investors to measure NIGHTINGALE HEALTH's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that NIGHTINGALE HEALTH's price fluctuation is very risky at this time. Calculation of the real value of NIGHTINGALE HEALTH is based on 3 months time horizon. Increasing NIGHTINGALE HEALTH's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the NIGHTINGALE stock is determined by what a typical buyer is willing to pay for full or partial control of NIGHTINGALE HEALTH EO. Since NIGHTINGALE HEALTH is currently traded on the exchange, buyers and sellers on that exchange determine the market value of NIGHTINGALE Stock. However, NIGHTINGALE HEALTH's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.81 | Real 2.6 | Hype 2.93 | Naive 3.15 |
The real value of NIGHTINGALE Stock, also known as its intrinsic value, is the underlying worth of NIGHTINGALE HEALTH Company, which is reflected in its stock price. It is based on NIGHTINGALE HEALTH's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of NIGHTINGALE HEALTH's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of NIGHTINGALE HEALTH EO helps investors to forecast how NIGHTINGALE stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of NIGHTINGALE HEALTH more accurately as focusing exclusively on NIGHTINGALE HEALTH's fundamentals will not take into account other important factors: NIGHTINGALE HEALTH EO Company Current Valuation Analysis
NIGHTINGALE HEALTH's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, NIGHTINGALE HEALTH EO has a Current Valuation of 0.0. This is 100.0% lower than that of the Healthcare sector and about the same as Health Information Services (which currently averages 0.0) industry. The current valuation for all Germany stocks is 100.0% higher than that of the company.
NIGHTINGALE Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses NIGHTINGALE HEALTH's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of NIGHTINGALE HEALTH could also be used in its relative valuation, which is a method of valuing NIGHTINGALE HEALTH by comparing valuation metrics of similar companies.NIGHTINGALE HEALTH is currently under evaluation in current valuation category among its peers.
NIGHTINGALE Fundamentals
| Return On Equity | -0.14 | |||
| Return On Asset | -0.0647 | |||
| Operating Margin | (5.88) % | |||
| Shares Outstanding | 39.09 M | |||
| Shares Owned By Insiders | 50.45 % | |||
| Shares Owned By Institutions | 16.00 % | |||
| Revenue | 2.31 M | |||
| Gross Profit | 1.28 M | |||
| EBITDA | (11.53 M) | |||
| Book Value Per Share | 1.85 X | |||
| Earnings Per Share | (0.25) X | |||
| Target Price | 1.3 | |||
| Number Of Employees | 71 | |||
| Market Capitalization | 66.28 M |
About NIGHTINGALE HEALTH Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze NIGHTINGALE HEALTH EO's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NIGHTINGALE HEALTH using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NIGHTINGALE HEALTH EO based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in NIGHTINGALE Stock
NIGHTINGALE HEALTH financial ratios help investors to determine whether NIGHTINGALE Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NIGHTINGALE with respect to the benefits of owning NIGHTINGALE HEALTH security.